Literature DB >> 33200234

Opportunities for pharmacogenomics-guided supportive care in cancer.

Jai N Patel1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33200234     DOI： 10.1007/s00520-020-05892-1

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  11 in total

Review 1.  Value of Supportive Care Pharmacogenomics in Oncology Practice.

Authors:  Jai N Patel; Lauren A Wiebe; Henry M Dunnenberger; Howard L McLeod
Journal:  Oncologist       Date:  2018-04-05

Review 2.  Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.

Authors:  J K Hicks; J R Bishop; K Sangkuhl; D J Müller; Y Ji; S G Leckband; J S Leeder; R L Graham; D L Chiulli; A LLerena; T C Skaar; S A Scott; J C Stingl; T E Klein; K E Caudle; A Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2015-06-29       Impact factor: 6.875

3.  Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.

Authors:  John F Greden; Sagar V Parikh; Anthony J Rothschild; Michael E Thase; Boadie W Dunlop; Charles DeBattista; Charles R Conway; Brent P Forester; Francis M Mondimore; Richard C Shelton; Matthew Macaluso; James Li; Krystal Brown; Alexa Gilbert; Lindsey Burns; Michael R Jablonski; Bryan Dechairo
Journal:  J Psychiatr Res       Date:  2019-01-04       Impact factor: 4.791

Review 4.  Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.

Authors:  G C Bell; K E Caudle; M Whirl-Carrillo; R J Gordon; K Hikino; C A Prows; A Gaedigk; Jag Agundez; S Sadhasivam; T E Klein; M Schwab
Journal:  Clin Pharmacol Ther       Date:  2017-04-06       Impact factor: 6.875

5.  Early palliative care for patients with metastatic non-small-cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

6.  Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.

Authors:  K A Birdwell; B Decker; J M Barbarino; J F Peterson; C M Stein; W Sadee; D Wang; A A Vinks; Y He; J J Swen; J S Leeder; Rhn van Schaik; K E Thummel; T E Klein; K E Caudle; I A M MacPhee
Journal:  Clin Pharmacol Ther       Date:  2015-06-03       Impact factor: 6.875

7.  Determinants of pain severity changes in ambulatory patients with cancer: an analysis from Eastern Cooperative Oncology Group trial E2Z02.

Authors:  Fengmin Zhao; Victor T Chang; Charles Cleeland; James F Cleary; Edith P Mitchell; Lynne I Wagner; Michael J Fisch
Journal:  J Clin Oncol       Date:  2013-12-23       Impact factor: 44.544

8.  Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.

Authors:  Katherine N Theken; Craig R Lee; Li Gong; Kelly E Caudle; Christine M Formea; Andrea Gaedigk; Teri E Klein; José A G Agúndez; Tilo Grosser
Journal:  Clin Pharmacol Ther       Date:  2020-04-28       Impact factor: 6.875

9.  Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes.

Authors:  Rolf Kaiser; Orhan Sezer; Anja Papies; Steffen Bauer; Claudia Schelenz; Pierre-Benoit Tremblay; Kurt Possinger; Ivar Roots; Jürgen Brockmöller
Journal:  J Clin Oncol       Date:  2002-06-15       Impact factor: 44.544

Review 10.  Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.

Authors:  K R Crews; A Gaedigk; H M Dunnenberger; J S Leeder; T E Klein; K E Caudle; C E Haidar; D D Shen; J T Callaghan; S Sadhasivam; C A Prows; E D Kharasch; T C Skaar
Journal:  Clin Pharmacol Ther       Date:  2014-01-23       Impact factor: 6.875
View more
  1 in total

1.  Cost-Effectiveness of Pharmacogenomics-Guided Prescribing to Prevent Gene-Drug-Related Deaths: A Decision-Analytic Model.

Authors:  Cathelijne H van der Wouden; Heiralde Marck; Henk-Jan Guchelaar; Jesse J Swen; Wilbert B van den Hout
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.